Michael S. Lee

5.0k total citations
197 papers, 3.3k citations indexed

About

Michael S. Lee is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael S. Lee has authored 197 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Surgery, 85 papers in Cardiology and Cardiovascular Medicine and 72 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael S. Lee's work include Coronary Interventions and Diagnostics (95 papers), Cerebrovascular and Carotid Artery Diseases (48 papers) and Acute Myocardial Infarction Research (37 papers). Michael S. Lee is often cited by papers focused on Coronary Interventions and Diagnostics (95 papers), Cerebrovascular and Carotid Artery Diseases (48 papers) and Acute Myocardial Infarction Research (37 papers). Michael S. Lee collaborates with scholars based in United States, South Korea and Italy. Michael S. Lee's co-authors include Raj Makkar, Saibal Kar, Joseph Aragon, Richard Shlofmitz, Evan Shlofmitz, James S. Forrester, Ehtisham Mahmud, Tae‐Hyun Yang, Jonathan M. Tobis and Will Finch and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

Michael S. Lee

190 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael S. Lee United States 31 2.3k 1.5k 965 797 242 197 3.3k
E. Hensor United Kingdom 50 1.2k 0.5× 575 0.4× 581 0.6× 403 0.5× 27 0.1× 175 7.8k
Peter S. Rose United States 44 3.8k 1.7× 596 0.4× 348 0.4× 2.6k 3.3× 30 0.1× 294 7.5k
Fatih Kantarcı Türkiye 28 999 0.4× 117 0.1× 521 0.5× 615 0.8× 153 0.6× 132 2.4k
Anne Grethe Jurik Denmark 43 1.8k 0.8× 248 0.2× 431 0.4× 428 0.5× 33 0.1× 223 6.6k
Laura W. Bancroft United States 29 1.1k 0.5× 224 0.2× 265 0.3× 970 1.2× 97 0.4× 117 2.6k
René Prêtre Switzerland 36 2.3k 1.0× 1.8k 1.2× 222 0.2× 1.8k 2.2× 46 0.2× 203 4.0k
Jeffrey J. Peterson United States 27 992 0.4× 211 0.1× 276 0.3× 906 1.1× 97 0.4× 73 2.4k
Erich Salomonowitz Austria 30 1.1k 0.5× 196 0.1× 873 0.9× 626 0.8× 26 0.1× 107 2.6k
Daniel A. Merton United States 35 758 0.3× 167 0.1× 1.0k 1.1× 1.3k 1.6× 100 0.4× 123 3.5k
Edouard Stauffer Switzerland 34 2.7k 1.2× 293 0.2× 109 0.1× 737 0.9× 34 0.1× 116 4.2k

Countries citing papers authored by Michael S. Lee

Since Specialization
Citations

This map shows the geographic impact of Michael S. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Lee more than expected).

Fields of papers citing papers by Michael S. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Lee. The network helps show where Michael S. Lee may publish in the future.

Co-authorship network of co-authors of Michael S. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Lee. A scholar is included among the top collaborators of Michael S. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Lee. Michael S. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kereiakes, Dean J., Richard Shlofmitz, Evan Shlofmitz, et al.. (2024). Coronary intravascular lithotripsy for severe coronary artery calcification: The Disrupt CAD I-IV trials. Cardiovascular revascularization medicine. 65. 81–87. 5 indexed citations
2.
Sweeney, Mark, Michael S. Lee, Henrike Maatz, et al.. (2024). Interleukin 11 therapy causes acute left ventricular dysfunction. Cardiovascular Research. 120(17). 2220–2235. 1 indexed citations
3.
Kim, Moo Hyun, Xuan Jin, Jong Sung Park, et al.. (2023). Statin therapy reduces dementia risk in atrial fibrillation patients receiving oral anticoagulants. European Heart Journal - Cardiovascular Pharmacotherapy. 9(5). 421–426. 4 indexed citations
4.
Kreutz, Rolf P., Anjali Prakash, Anjan Sinha, et al.. (2023). Heparin Dosing During Percutaneous Coronary Intervention and Obesity. Journal of Cardiovascular Pharmacology. 83(3). 251–257.
5.
Lee, Michael S., Dean J. Kereiakes, Evan Shlofmitz, et al.. (2023). Intravascular Lithotripsy for Calcified Left Main Artery Disease. Journal of the Society for Cardiovascular Angiography & Interventions. 2(6). 101126–101126. 3 indexed citations
6.
Choi, Byoung Geol, Seung‐Woon Rha, Min Woo Lee, et al.. (2023). Current Status of Cardiovascular Disease According to the Duration of Hypertension in Korean Adults. Global Heart. 18(1). 25–25.
7.
Lam, Helena, et al.. (2022). Transient Visual Obscurations Without Papilloedema as the Heralding Symptom of Chiasmal Compression. Neuro-Ophthalmology. 47(2). 106–109. 1 indexed citations
8.
Lee, Michael S., Byoung Geol Choi, & Seung‐Woon Rha. (2019). Impact of diabetes mellitus on 5-year clinical outcomes following successful endovascular revascularization for peripheral artery disease. Vascular Medicine. 25(1). 33–40. 7 indexed citations
9.
Shlofmitz, Evan, Richard Shlofmitz, & Michael S. Lee. (2019). The Role of Novel Oral Anticoagulants and Antiplatelet Therapy after Percutaneous Coronary Intervention: Individualizing Therapy to Optimize Outcomes. Korean Circulation Journal. 49(8). 645–645. 3 indexed citations
10.
Lee, Michael S., et al.. (2018). Acute Procedural Outcomes of Orbital Atherectomy for the Treatment of Profunda Femoris Artery Disease: Subanalysis of the CONFIRM Registries.. PubMed. 30(5). 177–181. 5 indexed citations
11.
Lee, Michael S., et al.. (2017). "Single-Operator" Technique for Advancing the Orbital Atherectomy Device.. PubMed. 29(3). 92–95. 5 indexed citations
12.
Lee, Michael S., Evan Shlofmitz, Gentian Lluri, & Richard Shlofmitz. (2017). Impact of Impaired Renal Function in Patients With Severely Calcified Coronary Lesions Treated With Orbital Atherectomy.. PubMed. 29(6). 203–206. 4 indexed citations
13.
Lee, Michael S., et al.. (2017). Incidence of Bradycardia and Outcomes of Patients Who Underwent Orbital Atherectomy Without a Temporary Pacemaker.. PubMed. 29(2). 59–62. 8 indexed citations
14.
Shlofmitz, Evan, Brad J. Martinsen, Michael S. Lee, et al.. (2017). Orbital atherectomy for the treatment of severely calcified coronary lesions: evidence, technique, and best practices. Expert Review of Medical Devices. 14(11). 867–879. 63 indexed citations
15.
Lee, Michael S.. (2017). Antibody-Mediated Rejection After Liver Transplant. Gastroenterology Clinics of North America. 46(2). 297–309. 21 indexed citations
16.
Lee, Michael S., et al.. (2016). Outcomes After Orbital Atherectomy of Severely Calcified Left Main Lesions: Analysis of the ORBIT II Study.. PubMed. 28(9). 364–9. 10 indexed citations
17.
Lee, Michael S., Robert Beasley, & George L. Adams. (2015). Impact of Advanced Age on Procedural and Acute Angiographic Outcomes in Patients Treated for Peripheral Artery Disease With Orbital Atherectomy: A CONFIRM Registries Subanalysis.. PubMed. 27(8). 381–6. 5 indexed citations
18.
Kim, Christopher Y., et al.. (2015). Gender differences in acute and 30‐day outcomes after orbital atherectomy treatment of de novo, severely calcified coronary lesions. Catheterization and Cardiovascular Interventions. 87(4). 671–677. 10 indexed citations
19.
Kollef, Marin H., Dilip Nathwani, Sanjay Merchant, et al.. (2009). MEDICAL RESOURCE UTILIZATION AMONG PATIENTS WITH VENTILATOR-ASSOCIATED PNEUMONIA: POOLED ANALYSIS OF RANDOMIZED STUDIES OF DORIPENEM VERSUS COMPARATORS. CHEST Journal. 136(4). 30S–30S. 1 indexed citations
20.
Lee, Michael S., et al.. (1993). Effects of Dithiol Malonate Derivatives ( DMDs ) on Carbon Tetrachloride-Induced Hepatotoxicity in Primary Cultures of Adult Rat Hepatocytes. Toxicological Research. 9(2). 167–175. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Hensor Breakdown of academic impact, for papers by Peter S. Rose Breakdown of academic impact, for papers by Fatih Kantarcı Breakdown of academic impact, for papers by Anne Grethe Jurik Breakdown of academic impact, for papers by Laura W. Bancroft Breakdown of academic impact, for papers by René Prêtre Breakdown of academic impact, for papers by Jeffrey J. Peterson Breakdown of academic impact, for papers by Erich Salomonowitz Breakdown of academic impact, for papers by Daniel A. Merton Breakdown of academic impact, for papers by Edouard Stauffer
Rankless by CCL
2026